GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Tiantan Biological Products Corp Ltd (SHSE:600161) » Definitions » Total Current Liabilities

Beijing Tiantan Biological Products (SHSE:600161) Total Current Liabilities : ¥1,449 Mil (As of Mar. 2024)


View and export this data going back to 1998. Start your Free Trial

What is Beijing Tiantan Biological Products Total Current Liabilities?

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Beijing Tiantan Biological Products's total current liabilities for the quarter that ended in Mar. 2024 was ¥1,449

Beijing Tiantan Biological Products Total Current Liabilities Historical Data

The historical data trend for Beijing Tiantan Biological Products's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Tiantan Biological Products Total Current Liabilities Chart

Beijing Tiantan Biological Products Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 651.94 954.71 809.58 1,157.35 1,279.62

Beijing Tiantan Biological Products Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,365.27 1,472.75 1,867.93 1,279.62 1,449.28

Beijing Tiantan Biological Products Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Beijing Tiantan Biological Products's Total Current Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=894.015+17.951
+Other Current Liabilities+Current Deferred Liabilities
=367.654+0
=1,280

Beijing Tiantan Biological Products's Total Current Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=942.72+14.71
+Other Current Liabilities+Current Deferred Liabilities
=491.845+0
=1,449

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Beijing Tiantan Biological Products Total Current Liabilities Related Terms

Thank you for viewing the detailed overview of Beijing Tiantan Biological Products's Total Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Tiantan Biological Products (SHSE:600161) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Tiantan Biological Products Corp Ltd (SHSE:600161) » Definitions » Total Current Liabilities
Comparable Companies
SZSE:002252 SZSE:300759 SZSE:002653 SZSE:002007 SZSE:301301 SZSE:002821 SHSE:688578 SHSE:603233 SHSE:688278 SHSE:688520 OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
N/A
Address
No. 4 Sanjianfang South Li, Zhongdan Center, Beijing, CHN, 100024
Website
http://www.tiantanbio.com
Beijing Tiantan Biological Products Corp Ltd is a China-based company engaged in the research and development, manufacturing, sales and consulting services for blood products. The company's blood products include Shanghai Blood Human Albumin, Shanghai blood system intravenous injection of human immunoglobulin, Guizhou blood human albumin, Rongsheng human albumin, Guizhou blood system static injection immunoglobulin, Rongsheng tetanus human immunoglobulin and others.
Executives
Wang Jian Ming Supervisors
Liu Ya Na Directors, senior managers
Fu Dao Xing Directors, senior managers
He Yan Lin Directors, senior managers
Hu Li Gang Director
Ci Xiang senior management
Yang Hui Chuan Director
Zhang Yi senior management
Wu Zhen Shan senior management

Beijing Tiantan Biological Products (SHSE:600161) Headlines

No Headlines